This news is delayed by 15 minutes, sign up now to get live news & full features.
SLNO SOLENO THERAPEUTICS INC
+ add to watchlist
$39.67
soleno therapeutics, inc. is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. the company is currently advancing its lead candidate, dccr, a once-daily oral tablet for the treatment of pws, into a phase iii clinical development program in early 2018.
Mkt Cap: $2.04B
52 Week High: $90.32
P/E: 0.00
52 Week Low: $29.43
Dividend: $0.00
Shares Outstanding: 51.62M